Colleen Gabel is a Dermatology physician. OpenAlex indexes 53 publications with 265 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1601 Congress St
Portland, ME 041022102
Telephone
207-661-0100Provider last certified this registry record 7 May 2026.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
21.7%Corticosteroid12.1%Triamcinolone Acetonide100%Part D≥28 patientsInterleukin-4 Receptor alpha Antagonist7.2%Dupixent Pen100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
20.6%Interleukin-17A Antagonist7.2%Taltz Autoinjector65%Cosentyx Sensoready (2 Pens)35%Part D<11 patientsCalcineurin inhibitor4%Tacrolimus100%Part D≥12 patients+ 3 more classes in this area
Anti-infectives
19.3%Azole Antifungal11%Ketoconazole100%Part D≥28 patientsTetracycline-class Drug5.5%Doxycycline Monohydrate100%Part D≥16 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 62101 A 6-year retrospective analysis of dermatology referrals for cancer patients at a Tertiary Academic Health System
Journal of the American Academy of Dermatology
2025 - Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study
Journal of the American Academy of Dermatology
2024 - A Case of Rapidly Progressive Unilateral Non-Nephrogenic Hemorrhagic Bullous Calciphylaxis Responding to Systemic Sodium Thiosulfate Therapy
WOUNDS A Compendium of Clinical Research and Practice
2024 - Prevalence and risk factors for development of recurrent calciphylaxis
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”